desipramine has been researched along with substance p in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bley, KR; Tsien, RW | 1 |
| Brodin, E; Luthman, J; Sundström, E; Wiehager, B | 1 |
| Fasmer, OB; Hole, K; Hunskaar, S | 1 |
| Hadzović, J; Stern, P | 1 |
| Jones, RS; Olpe, HR | 2 |
| Bartholini, G; Oblin, A; Zivkovic, B | 1 |
| Lester, BR; Sun, Z; Wilcox, GL; Wu, HH | 1 |
| Burnstock, G; Cavanagh, JF; Mione, MC | 1 |
| Ichikawa, H; Mitsushio, H; Shirayama, Y; Takahashi, K; Takashima, M | 1 |
| Diaz, J; Lammers, CH; Schwartz, JC; Sokoloff, P | 1 |
11 other study(ies) available for desipramine and substance p
| Article | Year |
|---|---|
Inhibition of Ca2+ and K+ channels in sympathetic neurons by neuropeptides and other ganglionic transmitters.
Topics: Animals; Calcium Channels; Cells, Cultured; Desipramine; Electric Conductivity; Electrophysiology; Epinephrine; Evoked Potentials; Ganglia, Sympathetic; Gonadotropin-Releasing Hormone; In Vitro Techniques; Muscarine; Neurons; Norepinephrine; Potassium Channels; Rana catesbeiana; Rana pipiens; Substance P; Sympathetic Nervous System | 1990 |
Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Cerebral Ventricles; Cholecystokinin; Desipramine; Dopamine; Hydroxydopamines; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Neuropeptides; Neurotensin; Neurotoxins; Norepinephrine; Organ Specificity; Oxidopamine; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1990 |
Antinociceptive effects of serotonergic reuptake inhibitors in mice.
Topics: Alanine; Analgesics; Animals; Citalopram; Clomipramine; Desipramine; Formaldehyde; Hot Temperature; Male; Mice; Neurotransmitter Uptake Inhibitors; Serotonin Antagonists; Substance P | 1989 |
Pharmacological analysis of central actions of synthetic substance P.
Topics: Aggression; Animals; Blood-Brain Barrier; Desipramine; Humans; Male; Mice; Morphine; Strychnine; Substance P; Substance Withdrawal Syndrome; Time Factors | 1973 |
Cortical neurone responsiveness to substance P is enhanced following chronic but not acute administration of desipramine.
Topics: Animals; Cerebral Cortex; Desipramine; Drug Interactions; Male; Neurons; Rats; Substance P; Time Factors | 1983 |
An increase in sensitivity of rat cingulate cortical neurones to substance P occurs following withdrawal of chronic administration of antidepressant drugs.
Topics: Action Potentials; Animals; Antidepressive Agents; Clomipramine; Desipramine; Diazepam; Drug Resistance; Fluphenazine; Gyrus Cinguli; Male; Neurons; Rats; Substance P; Time Factors; Trimipramine; Zimeldine | 1984 |
Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P.
Topics: Animals; Antipsychotic Agents; Desipramine; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Substance P; Substantia Nigra; Synaptic Transmission | 1984 |
Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Catecholamines; Cell Transplantation; Desipramine; Dioxanes; Idazoxan; Injections, Spinal; Male; Melanoma, Experimental; Mice; Mice, Inbred ICR; Morphine; Naloxone; Neoplasm Transplantation; Nociceptors; Pain Threshold; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spinal Cord; Substance P; Transplantation, Heterotopic | 1994 |
Uptake of 5-hydroxydopamine into non-sympathetic nerves of guinea-pig uterine artery in late pregnancy.
Topics: Animals; Arteries; Axons; Cocaine; Desipramine; Dopamine beta-Hydroxylase; Female; Guinea Pigs; Hydroxydopamines; Pregnancy; Pregnancy, Animal; Substance P; Time Factors; Uterus | 1993 |
Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat.
Topics: Amoxapine; Amygdala; Animals; Antidepressive Agents; Clomipramine; Corpus Striatum; Desipramine; Imipramine; Male; Mianserin; Radioimmunoassay; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Substance P; Substantia Nigra; Time Factors | 1996 |
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Dopamine; Dynorphins; Electroshock; Fluoxetine; Gene Expression; Imipramine; Islands of Calleja; Limbic System; Male; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substance P; Tranylcypromine | 2000 |